Stryker Corporation

SYK Healthcare Medical Devices

Stryker Corporation’s revenue for fiscal 2025 (year ended December 2025) was $25.1 billion, up 11.2% from fiscal 2024. In the quarter to June 2026, revenue grew 9.42%, EPS grew 43.1%, free cash flow grew 14.1% and total debt fell 9.88%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five, operating cash flow growth for three.

294.66 1.43 +0.49%
Market cap
$112.5B
P/E
30.3×
Fwd P/E
24.1×
Dividend yield
1.19%
F-score
5/9
Altman Z
4.81
Beneish M
−2.62
Dividend safety
82/100

Stryker Corporation 8-K filed Jan 29, 2026

Period ended Jan 29, 2026 · Filed · accepted 4:11 PM ET · Document on sec.gov · Filing index

2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits